Lancet 394 , 131138 (2019) O
Lower risk of hospitalisation for heart failure, kidney disease and death with sodium glucose co-transporter-2 compared to dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: a retrospective cohort study in UK primary care
These medications mimic the natural actions of GLP-1, improving insulin secretion, enhancing glucose management, and promoting weight loss in patients with type 2 diabetes or obesity
Matriel de laboratoire ncessaire : La reconstitution en laboratoire requiert : Eau bactriostatique pour la reconstitution (eau strile avec 0,9 % d'alcool benzylique) Matriel de prlvement strile pour la manipulation prcise des solutions reconstitues Conservation : placer immdiatement le flacon au rfrigrateur (2-8 C) ou au conglateur (-20 C) pour un stockage prolong
The ongoing dedicated ophthalmic trial named as FOCUS study, which aims to evaluate semaglutides long-term effects on diabetic retinopathy, is now ongoing and could contribute to a comprehensive understanding of the true risk-benefit profile of these agents in patients with or at risk for diabetic retinopathy (NCT03811561) [104]
Eriksson, J
